Utah Medical Products (UTMD) Equity Average (2016 - 2025)
Historic Equity Average for Utah Medical Products (UTMD) over the last 15 years, with Q3 2025 value amounting to $117.9 million.
- Utah Medical Products' Equity Average fell 502.08% to $117.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.9 million, marking a year-over-year decrease of 502.08%. This contributed to the annual value of $122.9 million for FY2024, which is 130.77% up from last year.
- Per Utah Medical Products' latest filing, its Equity Average stood at $117.9 million for Q3 2025, which was down 502.08% from $117.3 million recorded in Q2 2025.
- In the past 5 years, Utah Medical Products' Equity Average registered a high of $128.0 million during Q1 2024, and its lowest value of $103.9 million during Q1 2021.
- Its 5-year average for Equity Average is $115.7 million, with a median of $117.2 million in 2025.
- Its Equity Average has fluctuated over the past 5 years, first surged by 1382.1% in 2023, then plummeted by 842.83% in 2025.
- Quarter analysis of 5 years shows Utah Medical Products' Equity Average stood at $108.6 million in 2021, then increased by 2.45% to $111.2 million in 2022, then rose by 13.3% to $126.0 million in 2023, then decreased by 4.12% to $120.8 million in 2024, then dropped by 2.42% to $117.9 million in 2025.
- Its Equity Average stands at $117.9 million for Q3 2025, versus $117.3 million for Q2 2025 and $117.2 million for Q1 2025.